Controlled release coatings derived from aqueous dispersions of zein

• US 5,356,467 A
• Filed: 08/06/1993
• Issued: 10/18/1994
• Est. Priority Date: 08/13/1992
• Status: Expired due to Fees

• Current Assignee: Euroceltique SA
• Original Assignee: Euroceltique SA
• Inventors: Oshlack, Benjamin, Bodmeier, Roland, Chasin, Mark, McGinity, James
• Primary Examiner(s): BRUNSMAN, DAVID M
• Application Number:
  US08/103,887
• Time in Patent Office: 438 Days
• Field of Search: 530/373, 106/153, 252/174.13, 512/4, 71/64.11, 424/457, 424/468
• US Class Current: 106/161.1
• CPC Class Codes: A23J 3/18 from wheat
• CPC Class Codes: A23P 20/10 Coating with edible coatings, e.g. with oils or fats
• CPC Class Codes: A61K 9/2873 Proteins, e.g. gelatin
• CPC Class Codes: A61K 9/5052 Proteins, e.g. albumin
• CPC Class Codes: A61K 9/5078 with drug-free core
• CPC Class Codes: C08J 2389/00 Characterised by the use of proteins; Derivatives thereof
• CPC Class Codes: C08J 3/07 from polymer solutions
• CPC Class Codes: C08L 89/00 Compositions of proteins; Compositions of derivatives thereof foodstuff preparations A23J3/00
• CPC Class Codes: C09D 189/00 Coating compositions based on proteins; Coating compositions based on derivatives thereof foodstuff preparations A23J3/00

Abstract

Stable aqueous dispersions of zein which may be used as controlled release coatings of pharmaceutical, animal, health, or food products in an inorganic solvent-free environment are disclosed, as well as methods for preparing the same.

Claims

1. A stabilized aqueous dispersion of zein, comprising

an aqueous dispersion comprising from about 0.1 to about 10 percent zein w/v having a particle size from about 0.01 μ

m to about 10 μ

m, and

an amount effective to preserve said dispersion of a pharmaceutically acceptable preservative.

2. The stabilized aqueous dispersion of claim 1, wherein said pharmaceutically acceptable preservative is selected from the group consisting of benzalkonium chloride, benzoic acid, benzyl alcohol, methyl paraben, propyl paraben, ethyl paraben, butyl paraben, sorbic acid, a quaternary ammonium salt, phenol, cresol, mercury-containing preservatives, and mixtures of any of the foregoing.

3. The stabilized aqueous dispersion of claim 1, wherein said pharmaceutically acceptable preservative is selected from the group consisting of benzalkonium chloride, benzoic acid, methyl paraben, propyl paraben, and mixtures thereof.

4. The stabilized aqueous dispersion of claim 1, wherein said pharmaceutically acceptable preservative comprises methyl paraben in an amount of at least 0.05%, w/v.

5. The stabilized aqueous dispersion of claim 1, wherein said pharmaceutically acceptable preservative comprises about 0.2% methyl paraben and 0.02% propyl paraben, w/v.

6. The stabilized aqueous dispersion of claim 1, comprising from about 3 to about 8 percent zein, w/v.

7. The stabilized aqueous dispersion of claim 1, further comprising an effective amount of water-soluble plasticizer to provide a flexible film when said aqueous dispersion is applied to a substrate.

8. The stabilized aqueous dispersion of claim 1, wherein said water-soluble plasticizer is selected from the group consisting of glycerin, propylene glycol, polyethylene glycol, triethyl citrate, and mixtures of any of the foregoing.

9. The stabilized aqueous dispersion of claim 1, which has less than 20% sedimentation after 30 days.

10. A method of preparing a stable aqueous dispersion of zein, comprising adding a pharmaceutically acceptable preservative to an aqueous dispersion of zein comprising from about 0.1 to about 10 percent zein w/v having a particle size from about 0.01 microns to about 10 microns.

11. The method of claim 10, wherein said pharmaceutically acceptable preservative is selected from the group consisting of benzalkonium chloride, benzoic acid, benzyl alcohol, methyl paraben, propyl paraben, ethyl paraben, butyl paraben, sorbic acid, a quaternary ammonium salt, phenol, cresol, mercury-containing preservatives, and mixtures of any of the foregoing.

12. The method of claim 10, wherein said pharmaceutically acceptable preservative is selected from the group consisting of benzalkonium chloride, benzoic acid, methyl paraben, propyl paraben, and mixtures thereof.

13. The method of claim 10, wherein said pharmaceutically acceptable preservative comprises methyl paraben and propyl paraben in a ratio of about 10:

1, said methyl paraben being present in an amount of at least 0.05%, w/v

14. The method of claim 10, wherein said pharmaceutically acceptable preservative comprises about 0.2% methyl paraben and 0.02% propyl paraben, w/v.

15. A method for preparing an aqueous dispersion of zein, comprising

adding zein to a solvent mixture comprising water and from about 60 to about 90 percent of an organic solvent selected from the group consisting of ethanol, acetone,.and mixtures thereof, such that the zein dissolves in the solvent mixture,

precipitating the zein as fine particles by pouring said solution of zein as a thin stream into an aqueous phase under continuous stirring, to obtain an aqueous dispersion of zein comprising from about 0.1 to about 10 percent zein w/v,

evaporating said organic solvent from the mixture, concentrating the resulting aqueous phase to a zein concentration up to about 10% w/v, and

preserving the resulting aqueous dispersion of zein by adding an amount of effective to preserve said dispersion of a pharmaceutically acceptable preservative.

16. The method of claim 15, wherein said pharmaceutically acceptable preservative is selected from the group consisting of benzalkonium chloride, benzoic acid, benzyl alcohol, methyl paraben, propyl paraben, ethyl paraben, butyl paraben, sorbic acid, a quaternary ammonium salt, phenol, cresol, mercury-containing preservatives, and mixtures of any of the foregoing.

17. The method of claim 15, further comprising adding an effective amount of a pharmaceutically acceptable plasticizer to provide a flexible film, and thereafter applying said plasticized aqueous dispersion to a substrate.

18. The product produced by the method of claim 15.

19. A stabilized aqueous dispersion of zein, comprising

an aqueous dispersion comprising from about 0.1 to about 10 percent zein w/v and having a particle size from about 0.01 μ

m to about 10 μ

m, said aqueous dispersion obtained by precipitating zein by pouring a solution of zein in a solvent comprising water and from about 60 to about 90 percent organic solvent as a thin stream into an aqueous phase under continuous stirring, the organic solvent thereafter being substantially removed and the resulting aqueous phase concentrated, and

an amount effective to preserve said dispersion of a pharmaceutically acceptable preservative.

20. The stabilized aqueous dispersion of claim 19, wherein said organic solvent is selected from the group consisting of ethanol, acetone, and mixtures thereof.

21. The stabilized aqueous dispersion of claim 19, wherein said pharmaceutically acceptable preservative is selected from the group consisting of benzalkonium chloride, benzoic acid, benzyl alcohol, methyl paraben, propyl paraben, ethyl paraben, butyl paraben, sorbic acid, a quaternary ammonium salt, phenol, cresol, mercury-containing preservatives, and mixtures of any of the foregoing.

22. A solid controlled release formulation, comprising

a substrate comprising an active agent, said substrate coated with a controlled release coating to a weight gain from about 3 to about 15 percent, said controlled release coating comprising

(i) an aqueous dispersion of from about 0.1 to about 10 percent zein w/v having a particle size from about 0.01 μ

m to about 10 μ

m, said aqueous dispersion obtained by precipitating zein by pouring a solution of zein in a solvent comprising water and from about 60 to about 90 percent organic solvent as a thin stream into an aqueous phase under continuous stirring, the organic solvent thereafter being substantially removed and the resulting aqueous phase concentrated;

(ii) a pharmaceutically acceptable preservative;

(iii) a pharmaceutically acceptable plasticizer, the preservative and the plasticizer each being included in an amount necessary to provide a strong, continuous film capable of releasing the active agent at a desired rate when the formulation is exposed to an aqueous solution.

23. The controlled release formulation of claim 22, wherein said organic solvent is selected from the group consisting of ethanol, acetone, and mixtures thereof and said pharmaceutically acceptable preservative is selected from the group consisting of benzalkonium chloride, benzoic acid, benzyl alcohol, methyl paraben, propyl paraben, ethyl paraben, butyl paraben, sorbic acid, a quaternary ammonium salt, phenol, creosol, mercury-containing preservatives, and mixtures of any of the foregoing.

24. The controlled release formulation of claim 23, wherein said controlled release coating further comprises a pore-former which is dissolved, extracted or leached from the coating in the environment of use.

25. The controlled release formulation of claim 23, wherein said coating further comprises one or more release-modifying passageways formed in said coating.

26. The controlled release formulation of claim 23 which is a tablet.

27. The controlled release formulation of claim 22, wherein said pharmaceutically acceptable preservative comprises methyl paraben in an amount of at least 0.05%, w/v.

28. The controlled release formulation of claim 22, wherein said plasticizer is selected from the group consisting of glycerin, propylene glycol, polyethylene glycol, triethyl citrate, and mixtures of any of the foregoing.

29. The controlled release formulation of claim 22, wherein said active agent is selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic agent, a disinfecting and sanitizing agent, a cleansing agent, a fragrance agent and a fertilizing agent.

30. The controlled release formulation of claim 22, wherein said therapeutically active agent is selected From the group consisting of antihistamines, analgesics, non-steroidal anti-inflammatory agents, gastro-intestinals, anti-emetics, anti-epileptics, vasodilators, anti-tussive agents, expectorants, anti-asthmatics, hormones, diuretics, anti-hypotensives, bronchodilators, steroids, antibiotics, antivirals, antihemorrhoidals, hypnotics, psychotropics, antidiarrheals, mucolytics, sedatives, decongestants, laxatives, vitamins, and stimulants.

31. A method for preparing a controlled release formulation comprising a substrate coated with an aqueous dispersion of zein, comprising

adding zein to a solvent mixture comprising water and from about 60 to about 90 percent of an organic solvent selected from the group consisting of ethanol, acetone, and mixtures thereof, such that the zein dissolves in the solvent mixture,

precipitating the zein as fine particles by pouring said solution of zein as a thin stream into an aqueous phase under continuous stirring, to obtain an aqueous dispersion of zein comprising from about 0.1 to about 10 percent zein w/v,

evaporating said organic solvent from the mixture, concentrating the resulting aqueous phase to a zein concentration up to about 10% w/v,

adding effective amounts of a pharmaceutically acceptable preservative and a plasticizer,

coating a substrate comprising an active agent with a sufficient amount of the preserved, plasticized aqueous dispersion of zein to obtain a predetermined controlled release of said active agent when said coated substrate is exposed to fluid in an environment of use.

32. The method of claim 31, further comprising further controlling the release of said active agent by adding a pore-former which is dissolved, extracted or leached from the coating in the environment of use.

33. The method of claim 31, further comprising forming one or more release-modifying passageways in said coating.

34. The method of claim 31, wherein said water-soluble plasticizer is selected from the group consisting of glycerin, propylene glycol, polyethylene glycol, triethyl citrate, and mixtures of any of the foregoing.